Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
Summary
- All combined hormonal contraceptive methods are listed as Category 1 (no restriction for use) for women at high risk for HIV or with HIV or AIDS by the CDC Medical Eligibility Criteria for Contraceptive Use[CDC MEC; CDC MEC Summary]
- Efavirenz may decrease etonogestrel and levonorgestrel levels attained from implants[DHHS Perinatal; Leticee 2012; Scarsi 2015]
- Cobicistat may increase estrogen and progestin levels
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Drug-Drug Interactions, Pregnancy, Women